Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-26-005298
Filing Date
2026-01-16
Accepted
2026-01-16 19:59:12
Documents
1
Period of Report
2026-01-13

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 4657
  Complete submission text file 0001213900-26-005298.txt   6132
Mailing Address 22 EINSTEIN ST. FLOOR 4 NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST. FLOOR 4 NESS ZIONA L3 7414003 972 723942377
BiomX Inc. (Issuer) CIK: 0001739174 (see all company filings)

EIN.: 823364020 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address HASIRIM 48 GIRAT SHEMYEL L3 00000
Business Address
Yeganeh Reuven (Reporting) CIK: 0002044677 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38762 | Film No.: 26540803